East Aurora, NY, United States of America

Andrei V Gudkov

This inventor holds 72 USPTO granted patents and 21 published patent applications, plus 4 CIPO patents and 9 EPO patents, primarily in Cancer Treatment. Top assignees: The Cleveland Clinic Foundation, University of Illinois, Cleveland Biolabs, Inc.. Active years: 1997-2024.

USPTO Granted Patents = 72 (Patent Applications = 21)

% Patents Active = 61.1

CIPO Patents = 4 (Patent Applications = 3)

EPO Patents = 9 (Patent Applications = 12)

Average Co-Inventor Count = 2.3

ph-index = 11

Forward Citations = 436(Granted Patents)

Forward Citations (Not Self Cited) = 273(Dec 10, 2025)

Location History:

Chicago, IL (US) (1997 - 2006)
Glencoe, IL (US) (2000 - 2006)
Gates Mills, OH (US) (2005 - 2012)
Gate Mills, OH (US) (2014)
East Aurura, NY (US) (2015)
East Aurora, NY (US) (2011 - 2023)
Buffalo, NY (US) (2016 - 2023)

Company Filing History:

27 out of 1,070

The Cleveland Clinic Foundation

patents

24 out of 2,420

University of Illinois

patents

14 out of 16

Cleveland Biolabs, Inc.

Genome Protection, Inc.

patents

6. 3 out of 313

Health Research, Inc.

patents

7. 2 out of 2

Children's Cancer Institute Australia for Medical Research

University Technologies International, Inc.

patents

10. 1 out of 48

Ariel Scientific Innovations Ltd.

patents

11. 2 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Toll-Like Receptor Agonist

Flagellin-Based Agents

Inflammation Treatment

Carbazole Compounds

Apoptosis Modulation

Ionizing Radiation Protection

Oncoprotein Myc

Viral Vectors

Reperfusion Injuries

Therapeutic Uses

Lipopeptides

Cell Death Induction

72 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12115207 - Treatment of inflammation (2024-10-15),

2. 11628201 - Use of toll-like receptor agonist for treating cancer (2023-04-18),

3. 11542306 - Flagellin-based agents and uses including effective vaccination (2023-01-03),

4. 11235028 - Protection against stress-mediated damage from ionizing radiation (2022-02-01),

5. 10975127 - Flagellin-based agents and uses including effective vaccination (2021-04-13),

6. 10898543 - Flagellin related polypeptides and uses thereof (2021-01-26),

7. 10780152 - Use of toll-like receptor agonist for treating cancer (2020-09-22),

8. 10730915 - Flagellin-based agents and uses including effective vaccination (2020-08-04),

9. 10543251 - Flagellin related polypeptides and uses thereof (2020-01-28),

10. 10406206 - Protection against stress-mediated damage from ionizing radiation (2019-09-10),

11. 10336793 - Flagellin-based agents and uses including effective vaccination (2019-07-02),

12. 10265390 - Use of toll-like receptor agonist for treating cancer (2019-04-23),

13. 10137109 - Carbazole compounds and therapeutic uses of the compounds (2018-11-27),

14. 10086038 - Flagellin related polypeptides and uses thereof (2018-10-02),

15. 10034926 - Use of toll-like receptor agonist for treating cancer (2018-07-31),

Title: The Innovative Journey of Andrei V Gudkov

Introduction: Andrei V Gudkov is a renowned inventor based in East Aurora, NY (US) known for his groundbreaking contributions to the field of science and technology.

Latest Patents: Andrei V Gudkov holds several patents in the areas of biotechnology and cancer research, with his latest patents focusing on novel therapeutic approaches for combating various forms of cancer.

Career Highlights: With a distinguished career spanning several decades, Andrei V Gudkov has held key positions in leading research institutions and universities, where he has spearheaded pioneering research projects that have significantly advanced the field of biomedicine.

Collaborations: Throughout his career, Andrei V Gudkov has collaborated with top scientists, researchers, and industry experts to develop innovative solutions for complex medical challenges. His collaborative efforts have led to the development of cutting-edge technologies with far-reaching implications for healthcare.

Conclusion: Andrei V Gudkov's relentless pursuit of innovation and his commitment to pushing the boundaries of scientific discovery have established him as a trailblazer in the field of biotechnology. His work continues to inspire future generations of inventors and researchers to strive for excellence in their pursuit of groundbreaking discoveries.